What does Apnimed, Inc. do?
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying…
What is Apnimed, Inc.'s P/E and P/B ratio?
Apnimed, Inc. has a P/E ratio of 2.6 and a P/B ratio of -4.38.
What is Apnimed, Inc.'s debt-to-equity ratio?
Apnimed, Inc. has a debt-to-equity ratio of 1.30.
How much does Apnimed, Inc. owe compared with what it owns?
Apnimed, Inc. owes $1.90 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Apnimed, Inc.'s Positivity rank?
Apnimed, Inc. is ranked #6,398 of 6,774 companies globally and #3,664 of 4,000 in United States on PositoAI, with a Positivity Score of -18,689.
Does Apnimed, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Apnimed, Inc..
Where can I read the latest news about Apnimed, Inc.?
Recent headlines about Apnimed, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Apnimed, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Apnimed, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.